Hubungan Antara Kadar Homosistein Serum Dengan Skor Vitiligo Area Scoring Index pada Pasien Vitiligo

Teks penuh

(1)

DAFTAR PUSTAKA

1. Mateen A, Syed R, Alharbi KK, Khan IA. An Overview of Quality of Life in Vitiligo Patients – At Glance. Pigmentary Disorders S3: 003.2005. doi:10.4172/2376-0427.S3-003.

2. Ramakrishna P, Rajni T .Psychiatric Morbidity and Quality of Life in Vitiligo Patients.Indian J Psychol Med. 2014 Jul-Sep; 36(3): 302–3. doi: 10.4103/0253-7176.135385

3. Alikhan A, Felsten LM, Daly M, Petronic-Rosic V. Vitiligo: A comprehensive overview part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J Am Acad Dermatol [Internet] 2011[ cited 2015 Nov 25];65:473- 91. Available from:http://www.ncbi.nlm.nih.gov/ pubmed/ 21839315. 4. Jusuf NK, Meher C. Pola Kelainan Pigmentasi di Poliklinik Kulit dan

Kelamin Divisi Kosmetik RSUP H. Adam Malik Medan Tahun 20122015. Pertemuan Ilmiah Tahunan XV Ilmu Kesehatan Kulit dan Kelamin. Padang, Indonesia.

5. Rizal Y, Lestari S. Insidensi vitiligo di poliklinik kulit dan kelamin RSUP Dr. M Djamil Padang tahun 2001-2006. MDVI [Internet]. 2008 [cited 2015 Nov 26]; Januari 35 (1): 77. Available from: http://www.perdoski.org /index.php /public /information /mdvi-detail-content/77

6. Birlea SA, Spritz RA, Noris DA. Vitiligo. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffel DJ, Wolff K,editors. Fitzpatrick's dermatology in general medicine. 8th ed. New York: The MCGraw-Hill companies. 2012. p. 1308-24.

7. Sehgal VN, Srivastava G. Vitiligo: Compendium of clinico- epidemiological features. Indian J Dermatol Venereol Leprol. 2007;73:149- 56.

8. Yaghoobi R, Omidian M, Bagherani N. Vitiligo: A review of the published work. Journal of Dermatology. 2011;38:419-31. doi: 10.111 1/j.1346- 8138.2010.01139.x.

9. Karadag AS, Tutal E, Ertugrul DT, Akint KO, Bilgili SG. Serum holotranscobalamine, vitamin B12, folic acid and homocysteine levels in patients with vitiligo. Clin Exp Dermatol. 2011 April; 37: 62-4. doi:10.1111/j. 1365-2230.2011.04142.x.

10. Bolander-Gouaille C. Homocysteine, the new marker of disease risk-an overview. Business briefing: Europerisk-an pharmacotherapy. 2005;2-8. doi:10.1.1.199.9952.

11. Selhub J. Homocysteine metabolism. Annu. Rev Nutr. 1999; 19:217-46. doi:0199-9885/99/0715-0217$08.00.

12. Clarke S, Banfield K. S-Adenosylmethionine-dependent methyltransferases.In: Carmel R, Jacobsen DW, editors. Homocysteine in health and disease. Cambridge. Cambridge university press; 2001.p. 63-78 13. Agarwal S, Mendiratta V, Chander R, Jain A, Yadav P. Study of serum

(2)

15. Don P, Iuga A, Dacko A, Hardick K. Treatment of vitiligo with broadband ultraviolet B and vitamins. Int J Dermatol [Internet]. 2006 [ cited 2015 Nov 28] ; 45:63-5. Available from: http://www.ncbi. nlm.nih. gov/pubmed/ 16426381

16. Dicle O (2015) Assessment Methods in Vitiligo. Pigmentary Disorders 2:160. doi:10.4172/2376-0427.1000160

17. Alghamdi KM, Kumar A,Taieb A, Ezzedine K. Assessment methods for the evaluation of vitiligo.JEADV.2012. doi: 10.1111/j.1468-3083.2012.040 5.x

18. Vrijman C, Homan MWL, Limpens J, Veen WVD, Wolkerstorfer AW, Terwee CB, et al. Measurement properties of outcome measures for vitiligo. Arch Dermatol [Internet]. 2012 [cited 2015 Nov 28]; 148(11): 1302-9.Available from:http://www.ncbi.nlm.nih.gov/pubmed/ 22986764. 19. Sabry HH, Sabry JH, Hashim HM. Serum levels of homocysteine, vitamin

B12, and folic acid in vitiligo. Egypt J Dermatol Venerol [Internet] 2014 [cited 2015 Nov 29];34:65-9. Available from: http://www.ejdv.eg.net/text.asp?2014/34/l/65/137315.

20. Singh S, Singh U, Pandey SS. Serum folic acid, vitamin B12 and homocysteine levels in Indian vitiligo patients. EDOJ [ Internet]. 2012 June [ cited 2015 Nov 29]; 8(1):1-7. Available from: http :// www. edoj. org.eg/vol008/0801/002/01.htm.

21. Shaker OG, El-Tahlawi SMR. Is there a relationship between homocysteine and vitiligo? A pilot study. BJD. 2008; 159: 720-4. doi: 10.1111/J.1365- 2133.2008.08712.X.

22. Zaki AM, Abdo HM, Ibrahim IM, Ibrahim AEKI. Serum homocysteine and vitiligo. The gulf journal of dermatology and venereology[Internet]. 2014[ cited 2015 Nov 29] ; 21(2): 15-20.Availble from: https://www.google. com/url?sa=t&rct=j&q=&esrc =s& source=web&cd=3&ved= 0ahUKE wjzy8p1cnKAhVBBY4KHQnjB1EQFggrMAI&url=http%3A%2F%2Fww w.gulfdermajournal.com%2Fpdf%2F2014-10%2F2.pdf&usg=AFQjCN GX yvhhvl6trAe0SHRVAImXn0Yi1g&sig2=5MUvJNMVGIU_eS1rBkBO7A &cad=rja

23. Yasar A, Gunduz K, Onur E, Calkan M. Serum homocysteine, vitamin B12, folic acid levels and methylenetetrahydrofolate reductase (MTHFR) gene polymorphism in vitiligo. Disease markers. 2012; 33: 85-9. Doi: 10.3233/DMA-2012-0908.

24. Ghalamkarpour F Jafarian Z, Einollahi H, Younespour S. Homocysteine: is it a biomarker for vitiligo? Journal of pigmentary disorders. 2015; 2(4): 1-4. doi: 10.4172/2376-0427.1000172

25. Silverberg JI, Silverberg NB. Serum homocysteine as a biomarker of vitiligo vulgaris severity: A pilot study. J Am Acad Dermatbl. 2011. 64(2): 445-7. doi: 10.1016/j,jaad.2010.08.025.

26. Rahman MH, Amin MZ, Rahman M, Satter MA. A demographic study on vitiligo (sheti) in Bangladesh. Int J Res Med Sci. 2013; 1(2):123-8. doi: 10.5455/2320-6012.ijrms20130517.

(3)

of investigative dermatology. 1987; 88(4): 434-8. doi: 0022-202X/ 87/$03.50.

28. Spritz RA. Six decades of vitiligo genetics: genome-wide studies provide insights into autoimmune pathogenesis. J Invest Dermatol. 2012;132: 268- 73. doi: 10.1038/jid.2011.321.

29. Baum S, Barzilai A, Trau H. Vitiligo. In : Shoenfeld Y, Cervera R, Gershwin ME, editors. Diagnostic criteria in autoimmune diseases. Humana press [Internet]. 2008 [cited 2015 Dec 3].p. 353-8. Available from: http://link.springer.com/ book/ 10.1007%2F978-l-60327-285-8

30. Bowcock AM, Fernandez-Vina M. Targeting skin: vitiligo and autoimm unity. J Invest Dermatol. 2012; 132: 13-5. doi:10.103S /jid.201 1.353. 31. Wang CQF, Cruz-Inigo AE, Fuentes-Duculan J, Moussai D, Gulati N. Thl7

cells and activated dendritic cells are increased in vitiligo lesions. PLoS One. 2011 April; 6(4): 1-11. doi: 10.1371/journal.pone.0018907

32. Rezaei N, Gavalas NG, Weetman AP, Kemp EH. Autoimmunity as an aetiological factor in vitiligo. J Eur Acad Dermatol Venereol. 2007; 21: 865-876.doi: 10.1111/J.1468-3083.2007.02228.X.

33. Kemp EH, Emhemad S, Gawkrodger DJ, Weetman AP. Autoimmune disorders-pathogenic aspects. Chapter 14. p. 255-78. doi: 10.5772/802 34. Haider N, Islam MS, Al-Maraf A, Shohag MH, Ali R, Rahman GKMM,

Hasnat A. Oxidative stress and antioxidant status in vitiligo patients. Dhaka Univ J Pharm Sci. 2010 Dec; 9(2): 103-8. doi: 10.3329/dujps.v9i2.7894. 35. Naini FF, Shooshtari AV, Ebrahimi B, Molaei R. The effect of

pseudocatalase/superoxide dismutase in the treatment of vitiligo: a pilot study. J Res Pharm Pract 2012; 1:77-80. doi: 10.4 103/2279-042X. 108375. 36. Shin JW, Nam KM, Choi HR, Huh SY, Kirn SW, Youn SW, et al.

Erythrocyte malondialdehyde and glutathione levels in vitiligo patients. Ann Dermatol. 2010; 22(3): 279-83. doi: 10.5021/ad.2010.22.3.279.

37. Amin MZ, Rahman MH, Satter MA. Study of some biochemical parameters of vitiligo patients in Bangladesh. Bangladesh J Sci Ind Res [ Internet]. 2012 [ cited 2015 Dec 10]; 47(2): 173-86. Available from: . http://www.banglajol.info/index.php/BJSIR /article/view II 1449.

38. Esmaeili B, Rezaee SAR, Layegh P, Afshari JT, Dye P, Karimiani EG, et al Expression of IL-17 and COX2 gene in peripheral blood leukocytes of vitiligo patients. Iran J Allergy Asthma Immunol [Internet]. 2011 [cited 2015 Dec 11]; 10(2):81-9. Available from: http://www.sid.ir /en/VEWSSID/J_pdf/943201 10202.pdf.

39. Glassman SJ. Vitiligo, reactive oxygen species and T-cells. Clin Sci. 2011; 120: 99-120.doi: 10.1042/CS20090603.

(4)

41. Ezzedine K, Lifn HW, Suzuki T, Katayama I, Hamzavi I, Lan CCE, et al.Revised classification/nomenclature of vitiligo and related issues: the vitiligo global issues consensus conference . Pigment Cell Melanoma Res. 2012 May; 25(3): El-13. doi:10.1111/j.l755-148X.2012.00997.x.

42. Faria AR, Mira MT, Tarle RG, Castro CCS, Dellatore G. Vitiligo-part2 classification, histopathology and treatment. An Bras Dermatol. 2014;89(5):784-90.doi: 10.1590/abdl806-4841.20142717.

43. Taieb A, Alomar A, Bohm M, Dell'Anna ML, PAse D, Eleftheriadou V, et al. Guidelines for the management of vitiligo: the European dermatology forum concencus. BJD. 2012 July; 168:5-19. doi:10.1111/j.l365- 2133.2012.11197.x.

44. Brazelli V, Antoninetti M, Palazzini S, Barbagallo T, De Silvestri A, Borroni G. Critical evaluation of the variants influencing the clinical response of vitiligo: study of 60 cases treated with ultraviolet B narrow band phototherapy. J Eur Acad Dermatol Venereol. 2007;21:1369-74. doi: 10.1111/j.1468-3083.2007.02278.x.

45. Taieb A, Morice-Picard F, Jouary T, Ezzedine K, Cario^Andre M, Gauthier Y. Segmental vitiligo as the possible expression of cutaneous somatic mosaicism: implications for common non-segmental vitiligo. Pigment Cell Melanoma Res. 2008; 21:646-52. doi: 10.1111/j. 1755-148X.2008.00511.x. 46. Hann S, Chang J, Lee H, Kim S. The classification of segmental vitiligo on

the face. Yonsei Med J [Internet]. 2000 [ cited 2015 Dec 12]; 41(2): 209- 12. Available from:http://www.ncbi.nlm.nih.gov/pubmed/10817021.

47. Bhor U, Pande S. Scoring systems in dermatology. Indian J Dermatol Venereol Leprol [serial online] 2006 [cited 2015 Dec 13];72:315-21. Available from: http://www.ijdvl. com/text.asp?2006/72/4/315/26722. 48. Taieb A, Picardo M. The definition and assessment of vitiligo: a

consensus report of the Vitiligo European Task Force. Pigment Cell Res.2007; 20:27-35. doi: 10.1111/j.1600-0749.2006.00355.

49. Kawakami T, Hashimoto T. Disease severity indexes and treatment evaluation criteria in vitiligo. Dermatol Res Pract. 2011; 1-3. doi: 10.1155 72011/750342.

50. Hamzavi I, Hain H, McLean D, Shapiro J, Zeng H, Lui H. Parametric modeling of narrowband UVB phototherapy for vitiligo using a novel quantitative tool the vitiligo area scoring index. Arch Deermatol.2004;140:677-83.

51. Al-mutairi N, Nour-Eldin O. Vitiligo treatment update. GJDV [Internet]. 2003 Oct [cited 2015 Dec 14] ;10 (2): 1-13. Available from: http://www. gulfdermaj ournal. com/pdf/2003 -10/1 .pdf.

(5)

53.Felsten L, Alikhan A, Petronic-Rosic V. Vitiligo:A comprehensive overview part II: Treatment options and approach to treatment. J Am Acad Dermatol [Internet]. 2011[ cited 2015 Dec 16];65:493-514. Available from: http://www .ncbi.nlm. nih.gov/pubmed/21839316.

54.Gawkrodger DJ, Omerod AD, Shaw L, Mauri-sole I, Whitton ME, Watts MJ, et al.Guideline for the diagnosis and management of vitiligo. BJD.2008; 159: 1051-76. doi: 10.1111/j.1365-2133.2008. 08881.x

55.Clarke R. Lowering blood homocysteine with folic acid base supplements: meta-analysis of randomised trials. BMJ [Internet].1998[cited 2015 Dec 17]; 894-8. Available from: http://www. ncbi.nlm.nih.gov/pmc/articles/PMC28491/pdt7894.pdf.

56.Andre's E, Loukili NH, Noel E, Kaltenbach G, Abdelgheni MB, Perrin AE, et al. Vitamin B12 (cobalamin) deficiency in elderly patients. CMAJ [Internet]. 2004 [cited 2015 Dec 17] ; 17(3): 251-9. Availablefrom:http://www.researchgate.net/profile/Frederic_Maloisel/publi cation/8421627_Vitamin_B12_(cobalamin)_deficiency_in_elderly_pa tients/links/OOb49 52289e7cc6179000000.pdf.

57.Hustad S, Ueland PM, Vollset SE, Zhang Y, Bj0rke-Monsen AL, Schneede J. Riboflavin as a determinant of plasma total homocysteine: effect modification by the rnethylenetetrahydrofolate reductase C677T polymorphism. Clin Chem [ Internet]. 2000 [ cited 2015 Dec 18]; May 46 (8): 1065-71. Available from: http://www .clinchem . org/content/46/8/1065. Long.

58.Ubbink JB, Vermaak WJH, Merwe AVD, Becker PJ. Vitamin B-12,vitamin b-6, and folate nutritional status in men withhyperhomocysteinemia. Am J Clin Nutr [Internet]. 1993 [ cited 2015 Dec 19] ; 57: 47-53. Availabe from: http://ajcn. nutrition, org/ content'/57/l/47.1ong.

59. Bailey LB, Gregory JF. Folate metabolism and requirements. J. Nutr [Internet]. 1999 [cited 2015 Dec 19]; 129: 779-82. Available from: http://jn.nutrition.org /content/129/ 4/779. full.pdf+html.

60.Balci DD, Yunden Z, Yenin JZ, Okumus N. Serum homocysteine, folic acid and vitamin B12 levels in vitiligo. EJD. 2009 Jul-Aug; 19 (4): 382-3. doi:10.1684/ejd.2009.0671.

61.Becatti M, Prigano F, Fiorillo, Pescitelli L, Nassi P, Lotti T, Taddei N.The involvement of Smac/DIABLO, p53,NF-kB, and MAPK pathways in apoptosis of keratinocytes from perilesional vitiligft skin: protective effects of curcumin and capsaicin. Antioxidants & Redox Signaling. 2010; 13(9):1309-21. doi: 10.1089/ars.2009.2779.

(6)

63. Utama A. Gambaran penyakit vitiligo di RSUP Haji Adam Malik Medan tahun 2012-2014. S.Ked [Skripsi]. Medan: Universitas Sumatera Utara; 2015.

64. Rahmayanti ND, Rahmadewi. Studi Retrospektif: Profil Pasien Baru Vitiligo (A Retrospective Study: The Profile of New Patient with Vitiligo). Berkala Ilmu Kesehatan Kulit dan Kelamin – Periodical of Dermatology and Venereology. 2016 Aug; 28(2):52-8. doi: 10.20473/bikkk.V28.2.2016.52-58.

65. El-Dawela RE, Abou-elfetouh S. Relationship between homocysteine, vitamin B12, folic acid levels and vitiligo. J. Appl. Sci. Res .2012; 8(11): 5528-35.

66. Silverberg NB. The Epidemiology of Vitiligo. Curr Derm Rep. 2015 Jan; 4:36–43.doi: 10.1007/s13671-014-0098-6.

67. Jha BN. Assessment of Prevalence of Clinical and Sociodemographic Study of Vitiligo in Janaki Medical College, Nepal. 2016 Feb;ARJLS. 2(2):1 – 4. ISSN: 2455-3549.

68. Patil S, Gautam M, Nadkarni N, Saboo N, Godse K, Setia MS. Gender Differences in Clinicoepidemiological Features of Vitiligo: A CrossSectional Analysis. ISRN Dermatology. 2014 Feb;1-6. doi: 10.1155/2014/186197.

69. Elhuda. Hubungan kadar homosistei serum dengan skor vitiligo area scoring index (VASI) . Sp.DV [ Tesis]. Padang: Universitas Andalas; 2016.

70. Battezati A, Bertoli S, Romerio AS, Testolin G. Body composition: An important determinant of homocysteine and methionine concentrations in healthy individuals. NMCD. 2007 Sept; 17(7): 525–34. doi:10.1016/j.num ecd. 2006.03.006.

71. Dimitrova KR, DeGroot K, Myers AK, Kim YD. Estrogen and homocysteine. Cardiovacres. 2002 Feb; 53:577-88. doi: 10.1016/S0008-6363(01)00462-X 577-588.

72. Alomari MA, Khabour OF, Gharaibeh MY, Qhatan RA.Effect of physical activity on levels of homocysteine, folate, and vitamin B12 in the elderly. Phys Sportsmed. 2016 Feb; 44(1):68-73. doi: 10.1080/00913847.2016.113 5037.

73. Koehler KM, Baum RG, Gary PJ, Allen RH, Stabler SP, Rimm EB. Association of folate intake and serum homocysteine in elderly persons according to vitamin supplementation and alcohol use. Am J Clin Nutr. 2001 March ; 73:628–37. PMID:11237942.

Figur

Memperbarui...

Referensi

Memperbarui...